Abstract:Background: Obstructive sleep apnea -hypopnea syndrome (OSAHS) is associated with a higher prevalence of osteoporosis. However, the underlying mechanisms linking OSAHS with bone loss are still unclear. The aim of this study was to investigate the changes of receptor activator of nuclear factor-kappa B ligand (RANKL, an osteoclastogenesis-promoting factor) and osteoprotegerin (OPG, the decoy receptor for RANKL), oxidative stress and bone metabolism markers in OSAHS, in order to understand the potential mechanisms underlying bone loss in OSAHS patients. Methods: Forty-eight male patients with OSAHS, confirmed by polysotnnography (PSG) study, were enrolled. Twenty male subjects who were confirmed as not having OSAHS served as the controls. The subjects' bone mineral density (BMD) was assessed in lumbar spine and femoral neck using dual-energy X-ray absorptiometry (DXA). Blood samples were collected from all subjects for measurement of RANKL, OPG, the bone formation marker bone-specific alkaline phosphatase (BAP), the bone resorption marker tartrate-resistant acid phosphatase 5b (TRAP-5b), and total antioxidant capacity (TAOC). Results: The BMD and the T-score of the femoral neck and the lumbar spine were significantly lower in OSAHS patients as compared to the control group (P < 0.05). The serum level of BAP was significantly decreased in the OSAHS group (15.62 +/- 5.20 mu g/L) as compared to the control group (18.83 +/- 5.50 mu g/L, t= 2.235, P< 0.05), while the levels of TRAP-5b did not differ between the two groups (t= 1.447, P> 0.05). The serum level of OPG and the OPG/RANKL ratio were lower in the OSAHS group compared to the control group (both P< 0.05). TAOC level was also decreased significantly in the OSAHS group (P < 0.0S). Correlation analysis showed that the TAOC level was positively correlated with BAP in the OSAHS group (r= 0.248, P=0.04), but there were no correlations between TAOC and the BMD or the T-scores. The correlations between the level of OPG (or the OPG/RANKL ratio) and BMD or TAOC did not reach significance. Conclusion: In OSAHS patients, lower levels of TAOC were associated with decreased bone formation, suggesting a role of oxidative stress in bone loss, while the role of OPG/RANKL imbalance in bone metabolism in OSAHS needs further evaluation.

Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept

The Predictive Value of Plasma Thioredoxin Level for Obstructive Sleep Apnea-Hypopnea Syndrome

Change of Serum Levels of Thioredoxin in Patients with Severe Traumatic Brain Injury.

Association between the circulating superoxide dismutase and obstructive sleep apnea: a meta-analysis

Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation

Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Plasma tRF-16-79MP9PD and tRF-28-OB1690PQR304 as potential biomarkers for 4- to 7-year-old children with obstructive sleep apnea-hypopnea syndrome

The Novel Oxidative Stress Marker Thioredoxin is Increased in First-Episode Schizophrenic Patients.

Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.

Oxidative Stress Markers among Obstructive Sleep Apnea Patients

P66Shc is increased in peripheral blood mononuclear cells of the patients with obstructive sleep apnea

Changes of Plasma C-reactive Protein, Endothelin-1 and Tumor Necrosis Factor-Α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Relationship of Soluble Lectin-Like Oxidized LDL Receptor 1 with Severe Obstructive Sleep Apnea-Hypopnea Syndrome in Men

The Relationship between Oxidative Stress and Subjective Sleep Quality in People with Coronary Artery Disease

Imbalance of Osteoprotegerin/receptor Activator of Nuclear Factor-Κb Ligand and Oxidative Stress in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Metabolomic profiles predict clinical severity in patients with obstructive sleep apnea-hypopnea syndrome

Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea-a prospective intervention study

Plasma Expression of HIF‐1α As Novel Biomarker for the Diagnosis of Obstructive Sleep Apnea‐hypopnea Syndrome

Prognostic value of serum thioredoxin concentrations after intracerebral hemorrhage

[Role and Mechanism of Th17/Treg in Obstructive Sleep Apnea Hypopnea Syndrome].